Payment Please note: We DO NOT accept Credit Card payments for product value of a single unit over 1,500 USD
Introduction to GLP-1 Receptor Agonists GLP-1 receptor agonists are medications used for weight loss and type 2 diabetes management
The pipeline of next-generation treatments is advancing rapidly: Novo Nordisks CagriSema, a fixed-dose combination of semaglutide and the amylin analogue cagrilintide, has an FDA decision expected in late 2026 and could further accelerate the market
Wegovy Pill FDA Approval The FDA approved Wegovy tablets on December 22, 2025, following positive results from the OASIS 4 phase 3 clinical trial (NCT05564117)
The high dose (10 mg/kg) provided the most considerable protection, with neuronal and glial cells displaying near-normal arrangement and morphology in the cortical, hippocampal, and SN regions
Castaneda C